{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:46:30Z","timestamp":1772779590653,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NHS (London Specialised Commissioning Group)"},{"name":"Bristol-Myers Squibb"},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000046","name":"Abbott Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["MC_UU_12023\/26"],"award-info":[{"award-number":["MC_UU_12023\/26"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"GlaxoSmithKline foundation (GB)","award":["COL116446"],"award-info":[{"award-number":["COL116446"]}]},{"name":"Collaborative Initiative for Paediatric HIV Education and Research (CIPHER)","award":["158-INN"],"award-info":[{"award-number":["158-INN"]}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1065257"],"award-info":[{"award-number":["OPP1065257"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R01HD083042"],"award-info":[{"award-number":["1R01HD083042"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194132","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T17:32:28Z","timestamp":1522863148000},"page":"e0194132","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lipoatrophy\/lipohypertrophy outcomes after antiretroviral therapy switch in children in the UK\/Ireland"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3969-8680","authenticated-orcid":true,"given":"Steve","family":"Innes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intira Jeannie","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Fredric","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"ref1","article-title":"Lipodystrophy syndrome in HIV-infected children on HAART","author":"S Innes","year":"2009","journal-title":"South Afr J HIV Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1049732307311118","article-title":"Disclosure of HIV status: experiences and perceptions of persons living with HIV\/AIDS and nurses involved in their care in Africa","volume":"18","author":"M Greeff","year":"2008","journal-title":"Qual Heal Res"},{"key":"ref3","unstructured":"Nyblade L, Pande R, Mathur S, MacQuarrie K, Kidd R, Banteyerga H, et al. Disentangling HIV and AIDS stigma in Ethiopia, Tanzania and Zambia. Washington DC: International Center for Research on Women; 2003."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/09540120500456193","article-title":"Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003)","volume":"18","author":"P Peretti-Watel","year":"2006","journal-title":"AIDS Care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10461-008-9444-7","article-title":"Self-perception of body fat changes and HAART adherence in the Women\u2019s Interagency HIV Study","volume":"13","author":"M Plankey","year":"2008","journal-title":"AIDS Behav"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11904-006-0021-2","article-title":"Caring for adolescents with HIV","volume":"3","author":"P DeLaMora","year":"2006","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref7","article-title":"High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: A cross-sectional study","author":"S Innes","year":"2012","journal-title":"BMC Pediatr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/QAI.0b013e31824330cb","article-title":"Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors","volume":"59","author":"N Alam","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14656566.8.5.679","article-title":"Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment","volume":"8","author":"A Hill","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"ref10","article-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection [Internet]","year":"2013"},{"key":"ref11","article-title":"Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children","author":"S Innes","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1258\/ijsa.2011.011348","article-title":"Lipodystrophy and reversal of facial lipoatrophy in perinatally HIV-infected children and adolescents after discontinuation of stavudine","volume":"23","author":"N Sawawiboon","year":"2012","journal-title":"Int J STD AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/INF.0b013e31823f0e11","article-title":"Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"31","author":"L Aurpibul","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/135965350701200303","article-title":"Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz","volume":"12","author":"A Vigano","year":"2007","journal-title":"Antivir Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042560-200202010-00002","article-title":"Evidence of nucleoside analogue reverse transcriptase inhibitor\u2014associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients","volume":"29","author":"UA Walker","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"HC Cote","year":"2002","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/AAC.00914-09","article-title":"Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors","volume":"54","author":"M V Stankov","year":"2010","journal-title":"Antimicrob Agents Chemother. United States"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case-control study","volume":"361","author":"A Carr","year":"2003","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/135965350701200811","article-title":"Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"12","author":"L Aurpibul","year":"2007","journal-title":"Antivir Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","volume":"40","author":"DL Jacobson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref21","unstructured":"Grunfeld C. Basic science and metabolic disturbances. XIV International AIDS Conference. Barcelona, Spain; 2002."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/S2352-3018(15)00021-1","article-title":"Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study","volume":"2","author":"T Childs","year":"2015","journal-title":"Lancet HIV"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.inf.0000215003.32256.aa","article-title":"Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy","volume":"25","author":"K Hartman","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00126334-200301010-00015","article-title":"Agreement analysis of variables involved in lipodystrophy syndrome definition in HIV-infected patients","volume":"32","author":"WH Belloso","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/INF.0b013e3182755a34","article-title":"Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy","volume":"32","author":"GD Kinabo","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"ref27","article-title":"Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access [Internet]","year":"2010"},{"key":"ref28","article-title":"Guidelines for the Management of HIV in Children","year":"2010"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000230523.94588.85","article-title":"Body fat changes and lipodystrophy in HIV-infected children: impact of highly active antiretroviral therapy","volume":"43","author":"AB Dzwonek","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"A Carr","year":"2002","journal-title":"JAMA"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T02:06:22Z","timestamp":1660788382000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194132"}},"subtitle":[],"editor":[{"given":"Stephanie","family":"Shiau","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194132","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]}}}